Apart from melanoma, subsequent studies have suggested that MITF has multiple effects on cancers such as hepatocellular carcinoma [61], pancreatic cancer [62], lung cancer [63], and papillary renal cell carcinoma [64,65]. This evidence concerns the gene MITF and papillary renal cell carcinoma.